Clinical Trial Spotlight: Identifying Lung Cancer Patients Who Respond to Ponatinib

GRACE Videos and Articles

LCAM 2015


Dr. Ross Camidge discusses a clinical trial studying patients with advanced stage lung cancer to identify those who may respond to a drug called ponatinib. Both small cell and non small cell lung cancer patients may be eligible.

November is Lung Cancer Awareness Month. What are you grateful for?

Watch, read, and then share your own stories of empowerment in our online forum. Your story may inspire others.


[ratingwidget post_id=0]

Check out more LCAM videos & posts here.


Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation